1 results match your criteria: "Carraway Cancer Center[Affiliation]"
Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapy.
Am J Clin Oncol
December 1996
Carraway Cancer Center, Birmingham, Alabama 35234, USA.
This randomized, double-blind, parallel-group, multicenter study compared the antiemetic effectiveness, safety, and tolerability of two different intravenous (i.v.) doses of dolasetron mesylate (0.
View Article and Find Full Text PDF